tosufloxacin has been researched along with Urinary Tract Infections in 7 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty five patients with complicated urinary tract infections were treated with tosufloxacin (TFLX) in the initial antibacterial treatment." | 5.07 | [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection]. ( Arima, K; Hoshina, A; Kawamura, J; Nagano, M; Nakano, S; Saitou, K; Sakurai, M; Satani, H; Sugimura, Y; Tajima, K, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuji, Y | 1 |
| Okamura, K | 1 |
| Miyake, K | 1 |
| Ito, H | 1 |
| Kinukawa, T | 1 |
| Otani, T | 1 |
| Narushima, M | 1 |
| Kanai, S | 1 |
| Takagi, Y | 1 |
| Murase, T | 1 |
| Sakurai, M | 1 |
| Sugimura, Y | 1 |
| Arima, K | 1 |
| Kawamura, J | 1 |
| Saitou, K | 1 |
| Tajima, K | 1 |
| Nakano, S | 1 |
| Satani, H | 1 |
| Nagano, M | 1 |
| Hoshina, A | 1 |
| Fukuoka, Y | 1 |
| Ikeda, Y | 1 |
| Yamashiro, Y | 1 |
| Takahata, M | 1 |
| Todo, Y | 1 |
| Narita, H | 1 |
| Yamaguchi, K | 1 |
| Miyazaki, S | 1 |
| Kashitani, F | 1 |
| Iwata, M | 1 |
| Kanda, M | 1 |
| Tsujio, Y | 1 |
| Okada, J | 1 |
| Tazawa, Y | 1 |
| Watanabe, N | 1 |
| Uehara, N | 1 |
| Igari, J | 1 |
| Oguri, T | 1 |
| Kaimori, M | 1 |
| Kawamura, C | 1 |
| Iinuma, Y | 1 |
| Nisawataira, T | 1 |
| Tashiro, H | 1 |
| Ueno, K | 1 |
| Ishigo, S | 1 |
| Yasujima, M | 1 |
| Kawahara, S | 1 |
| Itoh, C | 1 |
| Yoshida, T | 1 |
| Yamanaka, K | 1 |
| Toyoshima, S | 1 |
| Katoh, J | 1 |
| Kudoh, M | 1 |
| Matsushima, T | 1 |
| Niki, Y | 1 |
| Miyashita, N | 1 |
| Funato, T | 1 |
| Kaku, M | 1 |
| Sato, N | 1 |
| Saito, Y | 1 |
| Ishii, K | 1 |
| Kuwabara, M | 1 |
| Hongo, T | 1 |
| Negayama, K | 1 |
| Kamihira, S | 1 |
| Miyazaki, Y | 1 |
| Takii, M | 1 |
| Ishii, M | 1 |
| Nakagawa, K | 1 |
| Ono, J | 1 |
| Takada, T | 1 |
| Murakami, N | 1 |
| Taira, M | 1 |
| Tamaki, I | 1 |
| Matsudou, Y | 1 |
| Nakasone, I | 1 |
| Fukushima, S | 1 |
| Moriyama, M | 1 |
| Miyamoto, H | 1 |
| Hosaka, M | 1 |
| Kubota, Y | 1 |
| Kinoshita, Y | 1 |
| Noguchi, K | 1 |
| Shuin, T | 1 |
| Noguchi, S | 1 |
| Yoshimura, S | 1 |
| Yoshida, K | 1 |
| Kobayashi, N | 1 |
| Saitoh, H | 1 |
| Negishi, T | 1 |
| Yamada, T | 1 |
| Watanabe, T | 1 |
| Kawakami, S | 1 |
| Tari, K | 1 |
| Satake, I | 1 |
| Ozawa, K | 1 |
| Suzuki, K | 1 |
| Nagata, Y | 1 |
3 trials available for tosufloxacin and Urinary Tract Infections
| Article | Year |
|---|---|
[Antibiotic prophylaxis for transurethral resection of the prostate--comparison of oral administration therapy with intravenous administration therapy].
Topics: Administration, Oral; Aged; Anti-Infective Agents; Cefotiam; Fever; Fluoroquinolones; Humans; Inject | 1993 |
[Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Male; Middl | 1994 |
[Clinical studies on tosufloxacin (TFLX) in urology].
Topics: 4-Quinolones; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cystitis; | 1992 |
4 other studies available for tosufloxacin and Urinary Tract Infections
| Article | Year |
|---|---|
In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Lung Diseases | 1993 |
[Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Ba | 2000 |
[Clinical efficacy of tosufloxacin on the patients with urinary tract infections].
Topics: 4-Quinolones; Adult; Aged; Anti-Infective Agents; Drug Evaluation; Female; Fluoroquinolones; Humans; | 1992 |
[Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988].
Topics: 4-Quinolones; Adolescent; Adult; Aged; Anti-Infective Agents; Bacteria; Drug Evaluation; Drug Resist | 1989 |